Skip to main content
. 2010 Jun 10;2010:170432. doi: 10.1155/2010/170432

Figure 1.

Figure 1

Tumors from Lynch Syndrome patients experience increased infiltration of tumors with CD3+ lymphocytes (b) compared to non-Lynch Syndrome patients (a).